Working… Menu

High-dose Chemotherapy and ASCT or Consolidating Conventional Chemotherapy in Primary CNS Lymphoma (MATRix)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02531841
Recruitment Status : Recruiting
First Posted : August 25, 2015
Last Update Posted : August 25, 2015
German Federal Ministry of Education and Research
International Extranodal Lymphoma Study Group (IELSG)
Information provided by (Responsible Party):
Elisabeth Schorb, University Hospital Freiburg

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : November 2017
Estimated Study Completion Date : December 2019
Publications of Results:

Publications automatically indexed to this study by Identifier (NCT Number):